BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aligholipour Farzani T, Földes K, Hanifehnezhad A, Yener Ilce B, Bilge Dagalp S, Amirzadeh Khiabani N, Ergünay K, Alkan F, Karaoglu T, Bodur H, Ozkul A. Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFNα/β/γR-/- Mice Models. Viruses 2019;11:E237. [PMID: 30857305 DOI: 10.3390/v11030237] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Tipih T, Heise M, Burt FJ. Immunogenicity of a DNA-Based Sindbis Replicon Expressing Crimean-Congo Hemorrhagic Fever Virus Nucleoprotein. Vaccines (Basel) 2021;9:1491. [PMID: 34960237 DOI: 10.3390/vaccines9121491] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Karaaslan E, Çetin NS, Kalkan-Yazıcı M, Hasanoğlu S, Karakeçili F, Özdarendeli A, Kalkan A, Kılıç AO, Doymaz MZ. Immune responses in multiple hosts to Nucleocapsid Protein (NP) of Crimean-Congo Hemorrhagic Fever Virus (CCHFV). PLoS Negl Trop Dis 2021;15:e0009973. [PMID: 34851958 DOI: 10.1371/journal.pntd.0009973] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Berber E, Çanakoğlu N, Tonbak Ş, Ozdarendeli A. Development of a protective inactivated vaccine against Crimean-Congo hemorrhagic fever infection. Heliyon 2021;7:e08161. [PMID: 34703927 DOI: 10.1016/j.heliyon.2021.e08161] [Reference Citation Analysis]
4 Rodríguez-Martín D, Rojas JM, Macchi F, Franceschi V, Russo L, Sevilla N, Donofrío G, Martín V. Immunization With Bovine Herpesvirus-4-Based Vector Delivering PPRV-H Protein Protects Sheep From PPRV Challenge. Front Immunol 2021;12:705539. [PMID: 34594325 DOI: 10.3389/fimmu.2021.705539] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 Ergünay K, Polat C, Özkul A. Vector-borne viruses in Turkey: A systematic review and bibliography. Antiviral Res 2020;183:104934. [PMID: 32949637 DOI: 10.1016/j.antiviral.2020.104934] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Sorvillo TE, Rodriguez SE, Hudson P, Carey M, Rodriguez LL, Spiropoulou CF, Bird BH, Spengler JR, Bente DA. Towards a Sustainable One Health Approach to Crimean-Congo Hemorrhagic Fever Prevention: Focus Areas and Gaps in Knowledge. Trop Med Infect Dis 2020;5:E113. [PMID: 32645889 DOI: 10.3390/tropicalmed5030113] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
7 Földes K, Aligholipour Farzani T, Ergünay K, Ozkul A. Differential Growth Characteristics of Crimean-Congo Hemorrhagic Fever Virus in Kidney Cells of Human and Bovine Origin. Viruses 2020;12:E685. [PMID: 32630501 DOI: 10.3390/v12060685] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Tipih T, Burt FJ. Crimean-Congo Hemorrhagic Fever Virus: Advances in Vaccine Development. Biores Open Access 2020;9:137-50. [PMID: 32461819 DOI: 10.1089/biores.2019.0057] [Cited by in Crossref: 6] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
9 Zivcec M, Spiropoulou CF, Spengler JR. The use of mice lacking type I or both type I and type II interferon responses in research on hemorrhagic fever viruses. Part 2: Vaccine efficacy studies. Antiviral Res 2020;174:104702. [PMID: 31982149 DOI: 10.1016/j.antiviral.2019.104702] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
10 Aligholipour Farzani T, Földes K, Ergünay K, Gurdal H, Bastug A, Ozkul A. Immunological Analysis of a CCHFV mRNA Vaccine Candidate in Mouse Models. Vaccines (Basel) 2019;7:E115. [PMID: 31527460 DOI: 10.3390/vaccines7030115] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
11 Spengler JR, Welch SR, Scholte FEM, Coleman-McCray JD, Harmon JR, Nichol ST, Bergeron É, Spiropoulou CF. Heterologous protection against Crimean-Congo hemorrhagic fever in mice after a single dose of replicon particle vaccine. Antiviral Res 2019;170:104573. [PMID: 31377243 DOI: 10.1016/j.antiviral.2019.104573] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
12 Garrison AR, Smith DR, Golden JW. Animal Models for Crimean-Congo Hemorrhagic Fever Human Disease. Viruses 2019;11:E590. [PMID: 31261754 DOI: 10.3390/v11070590] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 6.7] [Reference Citation Analysis]